摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

chloropalladium(1+);dipropoxy-sulfanylidene-sulfido-λ5-phosphane;triphenylphosphane | 209970-29-6

中文名称
——
中文别名
——
英文名称
chloropalladium(1+);dipropoxy-sulfanylidene-sulfido-λ5-phosphane;triphenylphosphane
英文别名
——
chloropalladium(1+);dipropoxy-sulfanylidene-sulfido-λ5-phosphane;triphenylphosphane化学式
CAS
209970-29-6
化学式
C24H29ClO2P2PdS2
mdl
——
分子量
617.446
InChiKey
YTDKYIXMALMPKA-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    chloropalladium(1+);dipropoxy-sulfanylidene-sulfido-λ5-phosphane;triphenylphosphane2-巯基吡啶钠盐二氯甲烷 为溶剂, 以85%的产率得到dipropoxy-sulfanylidene-sulfido-λ5-phosphane;palladium(2+);pyridine-2-thiolate;triphenylphosphane
    参考文献:
    名称:
    Synthesis and characterization of monomeric palladium(II) pyridine-2-chalcogenolate complexes
    摘要:
    Mononuclear palladium(II) complexes of the type [Pd(Epy)((SS)-S-boolean AND)(PPh3)] [E = S or Se; (SS)-S-boolean AND = S2CNEt2, S2P(OR)(2) (R = Et, Pr-n, Pr-i)] have been prepared. All the complexes have been characterized by elemental analysis and NMR (H-1, P-31{H-1}, Se-77{H-1}) spectral data. The NMR data indicate that there are two species in solution, i.e. one with chelating (SS)-S-boolean AND ligand predominates (similar to 95%) while the other with chelating Epy and monodentate (SS)-S-boolean AND existing in similar to 5% concentration. The X-ray crystal structure of [Pd(Spy){S2P(OPri)(2)}(PPh3)] has been determined. The square planar palladium atom is coordinated to asymmetrically chelated ((PrO)-O-i)(2)PS2- ligand, PPh3 and pyS(-) groups. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0277-5387(98)00426-4
点击查看最新优质反应信息

文献信息

  • Pyridine-2-selenolate complexes of palladium(II) and platinum(II): crystal structure of [(Prn3P)Cl2Pd(NC5H4Se)PdCl(PPrn3)]
    作者:Sanjay Narayan、Vimal K. Jain、Babu Varghese
    DOI:10.1039/a800758f
    日期:——
    Reactions of sodium pyridine-2-selenolate with several palladium(II) and platinum(II) complexes were carried out and a variety of products isolated and characterized. Treatment of [M2Cl2(µ-Cl)2(PR3)2] with NaSeC5H4N readily afforded complexes of the type [MCl(NC5H4Se)(PR3)] 1 (M = Pd or Pt; PR3 = PEt3, PPrn3, PBun3, PMe2Ph, PMePh2 or PPh3). Some of the complexes containing trialkylphosphine existed as binuclear species, [M2Cl2(µ-NC5H4Se)2(PR3)2] 2 in ≈5% concentration in solution. Reaction of [MCl(NC5H4Se)(PR3)] with [M2Cl2(µ-Cl)2(PR3)2] gave an unusual series of binuclear complexes, [(R3P)Cl2M(NC5H4Se)MCl(PR3)] 3, in which NC5H4Se acts simultaneously as a Se bridging and Se,N chelating ligand. Reactions of [PtCl2(cod)] or Na2[PdCl4] with NaSeC5H4N afforded [M(NC5H4Se)2}n]. Similar reactions with [MCl2(L–L)] and [MCl2(PPh3)2] (L–L = dppm or dppe) gave [M(NC5H4Se)2(L–L)] and [M(NC5H4Se)2(PPh3)2], respectively. The latter complex exists in a dynamic equilibrium with [M(NC5H4Se)(NC5H4Se-N,Se)(PPh3)2] and PPh3. All the complexes were characterized by elemental analyses and NMR (1H, 31P, 77Se, 195Pt) spectral data. The crystal structure of [(Prn3P)Cl2Pd(NC5H4Se)PdCl(PPrn3)] revealed that NC5H4Se acts as a triply bridging ligand. One of the palladium atoms is co-ordinated to two trans chlorine atoms, one PPrn3, and a Se atom, while the second is bound to a chelating NC5H4Se ligand, a chlorine atom and a PPrn3 ligand.
    吡啶-2-酯与几种(II)和(II)配合物的反应进行了研究,并分离和表征了多种产物。用NaSeC5H4N处理[M2Cl2(μ-Cl)2(PR3)2],很容易得到类型为[MCl(NC5H4Se)(PR3)]的配合物1(M=Pd或Pt;PR3=PEt3, PPrn3, PBun3, PMe2Ph, PMePh2或PPh3)。一些含有三烷基膦的配合物以双核种类[M2Cl2(μ-NC5H4Se)2(PR3)2] 2的形式在溶液中约以5%的浓度存在。[MCl(NC5H4Se)(PR3)]与[M2Cl2(μ-Cl)2(PR3)2]的反应得到了一个不寻常的双核配合物系列[(R3P)Cl2M(NC5H4Se)MCl(PR3)] 3,其中NC5H4Se同时作为Se桥接和Se,N螯合配体作 用。[PtCl2(cod)]或Na2[PdCl4]与NaSeC5H4N的反应得到[M(NC5H4Se)2}n]。与[MCl2(L–L)]和[MCl2(PPh3)2](L–L=dpPM或dppe)的类似反应分别得到了[M(NC5H4Se)2(L–L)]和[M(NC5H4Se)2(PPh3)2]。后者在动态平衡中存在与[M(NC5H4Se)(NC5H4Se-N,Se)(PPh3)2]和PPh3。所有配合物都通过元素分析和核磁共振(1H, 31P, 77Se, 195Pt)光谱数据进行了表征。[(Prn3P)Cl2Pd(NC5H4Se)PdCl(PPrn3)]的晶体结构显示,NC5H4Se作为一个三重桥接配体。一种原子与两个反式原子,一个PPrn3和一个Se原子配位,而另一种则与螯合的NC5H4Se配体,一个原子和一个PPrn3配体结合。
  • Synthesis and structural characterization of chalcogenido-bridged trinuclear palladium(II) dialk ldithiophosphates, [Pd3(μ3-E)2 {S2(OR)2}2(PR3′)2] (E = S or Se, R = Et, Pr , Pr , Bu and R′ = Ph, Et)
    作者:Sanjay Narayan、Vimal K. Jain、R.J. Butcher
    DOI:10.1016/s0277-5387(97)00474-9
    日期:1998.5
    of [PdClS2P(OR)2}(PR′3)] with sodium sulfide or selenide in acetone afforded neutral trinuclear palladium(II) complexes of the type [Pd3(μ3-E)2S2P(OR)2}2(PR′3)2] (E = S or Se; R = Et, Prn Pri, Bus, R′ = Et or Ph) in 24–42% yield. These complexes were characterized by elemental analysis, NMR (1H, 31P, 77Se) and FAB mass spectral data. The molecular structure of [Pd3(μ3-S)2S2P(OEt)2}2(PPh3)2] (1) was
    [的PdCl S的反应2 P(OR)2,在丙酮}(PR'3)],得到中性三核(II)的类型的配合物[3(μ 3 -E)2 S 2 P(OR)2 } 2(PR' 3)2 ](E = S或Se; R =乙基,丙基ñ我,卜小号,R'=的Et或pH)在24-42%的产率。这些配合物通过元素分析,NMR(1 H,31 P,77 Se)和FAB质谱数据进行表征。[Pd 3(μ通过X射线衍射测定3 -S)2 S 2 P(OEt)2 } 2(PPh 3)2 ](1)。该分子由三个扭曲的正方形平面原子共享两个的μ 3 -S配体原子中的一个与两个三苯基膦配体连接,而其余两个原子中的每个与螯合的二硫代磷酸酯基团配位。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫